(Q30235522)

11 June 2017

0 references

Autologous serum eye drops for dry eye. (English)

1 reference

11 June 2017

Qing Pan

1

1 reference

11 June 2017

Adla Angelina

2

1 reference

11 June 2017

Michael Marrone

3

1 reference

11 June 2017

Walter J Stark

4

1 reference

11 June 2017

Esen K Akpek

5

1 reference

11 June 2017

publication date

28 February 2017

1 reference

Cochrane Database of Systematic Reviews

11 June 2017

published in

1 reference

11 June 2017

volume

2

1 reference

11 June 2017

page(s)

CD009327

1 reference

The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study

11 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Controlled study of the use of autologous serum in dry eye patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Ocular manifestations of graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Serum growth factor analysis in dry eye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Neurotrophic keratopathy--a post-LASIK case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Autologous serum eye drops for ocular surface disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Autologous serum eye drops for the treatment of dry eye diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Comparative Evaluation of Silicone Hydrogel Contact Lenses and Autologous Serum for Management of Sjögren Syndrome-Associated Dry Eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Comparative role of 20% cord blood serum and 20% autologous serum in dry eye associated with Hansen's disease: a tear proteomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

The pathology of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Dysfunctional tear syndrome: a Delphi approach to treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Ocular complications of systemic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

A comparison of faces scales for the measurement of pediatric pain: children's and parents' ratings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Rationale for anti-inflammatory therapy in dry eye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Pharmacotherapy of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Punctal occlusion for dry eye syndrome

26 November 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

The evolving treatment of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Sjögren's syndrome in dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Topical fibronectin ophthalmic solution in the treatment of persistent defects of the corneal epithelium. Chiron Vision Fibronectin Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Growth factors: importance in wound healing and maintenance of transparency of the cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Autologous serum in the management of recalcitrant dry eye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Correlation of the Schirmer 1 and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Autologous serum application in the treatment of neurotrophic keratopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

The epidemiology of dry eye in Melbourne, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Topical fibronectin therapy in persistent corneal ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Immunoglobulin deposition in the cornea after application of autologous serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

The repeatability of clinical measurements of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Fibronectin. A new therapy for corneal trophic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Dry eye diagnosis and management in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Antiinflammatory therapy for dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Over the counter (OTC) artificial tear drops for dry eye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Autologous serum for ocular surface diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Relation between signs and symptoms of dry eye in the elderly. A population-based perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

The role of the lacrimal functional unit in the pathophysiology of dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Treatment of dry eye by autologous serum application in Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Serum application for the treatment of ocular surface disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Test results in patients with Sjögren's syndrome defined by the Japanese criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Autologous serum eye drops for dry eye syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Autologous serum eye drops for dry eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Management of Ocular Surface Inflammation in Sjögren Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009327.PUB3

Treatment of Sjögren's syndrome-associated dry eye an evidence-based review

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Preservatives in eyedrops: the good, the bad and the ugly

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Management of dry eye disease

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Autologous serum therapy of the ocular surface with novel delivery by platelet concentrate gel.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

How to identify randomized controlled trials in MEDLINE: ten years on

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Autologous serum eye drops for dry eye after LASIK.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Treatment of persistent epithelial defects using autologous serum application

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Ocular surface treatment before laser in situ keratomileusis in patients with severe dry eye.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Prevalence of dry eye syndrome among US women

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Ocular manifestations of autoimmune disease.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Topical fibronectin in the treatment of persistent corneal epithelial defects and trophic ulcers

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Corneal sensitivity after photorefractive keratectomy.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5510593

Tear film and ocular surface abnormalities after eyelid tattooing

26 November 2018

1 reference

12 December 2020

[Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application]

1 reference

12 December 2020

Tear film osmolarity: determination of a referent for dry eye diagnosis

1 reference

12 December 2020

Stability of epitheliotrophic factors in autologous serum eye drops from chronic Stevens-Johnson syndrome dry eye compared to non-autoimmune dry eye

1 reference

12 December 2020

The effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes

1 reference

12 December 2020

Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease

1 reference

12 December 2020

The effect of autologous serum eye drops in the treatment of severe dry eye disease: a prospective randomized case-control study

1 reference

12 December 2020

Clinical Trials of Therapeutic Ocular Surface Medium for Moderate to Severe Dry Eye

1 reference

12 December 2020

A natural solution to dry eye?

1 reference

12 December 2020

1 reference

12 December 2020

An optimised protocol for the production of autologous serum eyedrops

1 reference

12 December 2020

Staining characteristics and antiviral activity of sulforhodamine B and lissamine green B

1 reference

12 December 2020

Ocular surface disease index for the diagnosis of dry eye syndrome

1 reference

12 December 2020

Physiological concentrations of human epidermal growth factor in biological fluids: use of a sensitive enzyme immunoassay

1 reference

12 December 2020

Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms

1 reference

12 December 2020

Falta de concordancia entre los cuestionarios y las pruebas diagnósticas en el síndrome de ojo seco

1 reference

12 December 2020

Clinical Experience With a Mobile Ocular Perfusion Pump

1 reference

12 December 2020

Tear osmolarity in the diagnosis and management of dry eye disease

1 reference

12 December 2020

[Sjogren's syndrome and its therapy. A therapeutic attempt using antilymphocyte serum]

1 reference

12 December 2020

Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea

1 reference

12 December 2020

[Autologous serum and alternative blood products for the treatment of ocular surface disorders]

1 reference

12 December 2020

Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group

1 reference

12 December 2020

Low-cost protocol for the production of autologous serum eye drops by blood collection and processing centres for the treatment of ocular surface diseases

1 reference

12 December 2020

GVHD dry eyes treated with autologous serum tears

1 reference

12 December 2020

Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome

1 reference

12 December 2020

Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome

1 reference

12 December 2020

Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca

1 reference

12 December 2020

Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sjögren syndrome

1 reference

12 December 2020

The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)

1 reference

12 December 2020

10.1002/14651858.CD009327.PUB3

Identifiers

DOI

1 reference

11 June 2017

0 references

1 reference